• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

熊去氧胆酸通过调节氨基酸、黄酮类化合物和脂肪酸代谢途径发挥保肝作用。

Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways.

机构信息

Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.

Department of Clinical Pharmacology and Toxicology, Korea University Guro Hospital, Seoul, South Korea.

出版信息

Metabolomics. 2019 Feb 27;15(3):30. doi: 10.1007/s11306-019-1494-5.

DOI:10.1007/s11306-019-1494-5
PMID:30830474
Abstract

INTRODUCTION

Ursodeoxycholic acid (UDCA) is an intestinal bacterial metabolite with hepatoprotective effects. However, molecular mechanisms underlying its effects remain unclear.

OBJECTIVES

The aim of this study was to investigate the mechanisms underlying the therapeutic effects of UDCA by using global metabolomics analyses in healthy subjects.

METHODS

Healthy Korean men were administered UDCA at dosage of 400, 800, or 1200 mg daily for 2 weeks. Serum samples were collected and used for liver function tests and to determine miR-122 expression levels. Urinary and plasma global metabolomics analyses were conducted using a liquid chromatography system coupled with quadrupole-time-of-flight mass spectrometry (LC/QTOFMS) and gas chromatography-TOFMS (GC/TOFMS). Unsupervised multivariate analysis (principal component analysis) was performed to identify discriminative markers before and after treatment.

RESULTS

Alanine transaminase score and serum miR-122 levels decreased significantly after 2 weeks of treatment. Through LC- and GC-based metabolomic profiling, we identified 40 differential metabolites in plasma and urine samples.

CONCLUSIONS

Regulation of liver function scores and metabolic alternations highlight the potential hepatoprotective action of UDCA, which were primarily associated with amino acid, flavonoid, and fatty acid metabolism in healthy men.

摘要

简介

熊去氧胆酸(UDCA)是一种具有肝脏保护作用的肠道细菌代谢物。然而,其作用的分子机制尚不清楚。

目的

本研究旨在通过对健康受试者的全代谢组学分析,探讨 UDCA 治疗作用的机制。

方法

健康韩国男性每天服用 UDCA 剂量为 400、800 或 1200mg,持续 2 周。采集血清样本进行肝功能检查和 miR-122 表达水平测定。使用液相色谱系统与四极杆飞行时间质谱(LC/QTOFMS)和气相色谱-飞行时间质谱(GC/TOFMS)进行尿液和血浆全代谢组学分析。采用无监督多元分析(主成分分析)对治疗前后的鉴别标志物进行分析。

结果

治疗 2 周后,丙氨酸氨基转移酶评分和血清 miR-122 水平显著下降。通过基于 LC 和 GC 的代谢组学分析,我们在血浆和尿液样本中鉴定出 40 种差异代谢物。

结论

肝功能评分的调节和代谢变化突出了 UDCA 的潜在肝脏保护作用,这主要与健康男性的氨基酸、类黄酮和脂肪酸代谢有关。

相似文献

1
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways.熊去氧胆酸通过调节氨基酸、黄酮类化合物和脂肪酸代谢途径发挥保肝作用。
Metabolomics. 2019 Feb 27;15(3):30. doi: 10.1007/s11306-019-1494-5.
2
Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.基于液相色谱-四极杆飞行时间质谱的代谢综合征患者代谢组学特征研究。
Ann Endocrinol (Paris). 2018 Feb;79(1):37-44. doi: 10.1016/j.ando.2017.05.005. Epub 2017 Dec 13.
3
Metabolite profiling analysis of hepatitis B virus-induced liver cirrhosis patients with minimal hepatic encephalopathy using gas chromatography-time-of-flight mass spectrometry and ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.采用气相色谱-飞行时间质谱和超高效液相色谱-四极杆-飞行时间质谱对乙型肝炎病毒所致肝硬化合并轻微肝性脑病患者进行代谢物谱分析。
Biomed Chromatogr. 2023 Jan;37(1):e5529. doi: 10.1002/bmc.5529. Epub 2022 Nov 17.
4
Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.使用液相色谱/质谱联用技术对胃癌进行代谢组学分析
Appl Biochem Biotechnol. 2015 Aug;176(8):2170-84. doi: 10.1007/s12010-015-1706-z. Epub 2015 Jun 19.
5
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.超重肝功能异常人群中熊去氧胆酸的药代动力学和药效学。
Clin Pharmacol Drug Dev. 2021 Jan;10(1):68-77. doi: 10.1002/cpdd.790. Epub 2020 Mar 19.
6
delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.δ22-熊去氧胆酸是大鼠体内给予熊去氧胆酸后的一种独特代谢产物,表明部分β-氧化是胆汁酸代谢的主要途径。
Biochemistry. 1995 Apr 4;34(13):4169-78. doi: 10.1021/bi00013a004.
7
Urinary metabolomics study the mechanism of Taohong Siwu Decoction intervention in acute blood stasis model rats based on liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.基于液相色谱-四极杆飞行时间质谱联用技术的尿代谢组学研究桃红四物汤对急性血瘀模型大鼠的干预机制
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:51-60. doi: 10.1016/j.jchromb.2017.12.035. Epub 2018 Jan 2.
8
Metabonomic Profiling Reveals Cancer Chemopreventive Effects of American Ginseng on Colon Carcinogenesis in Apc(Min/+) Mice.代谢组学分析揭示西洋参对Apc(Min/+)小鼠结肠癌发生的化学预防作用。
J Proteome Res. 2015 Aug 7;14(8):3336-47. doi: 10.1021/acs.jproteome.5b00388. Epub 2015 Jul 10.
9
Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.甲状腺乳头状癌和甲状腺良性腺瘤的独特代谢组学特征
J Proteome Res. 2015 Aug 7;14(8):3315-21. doi: 10.1021/acs.jproteome.5b00351. Epub 2015 Jul 8.
10
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.熊去氧胆酸通过苯丙氨酸/酪氨酸途径和肝功能障碍患者的微生物组重塑改善肝功能。
Sci Rep. 2018 Aug 8;8(1):11874. doi: 10.1038/s41598-018-30349-1.

引用本文的文献

1
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes.线粒体编码肽MOTS-c可预防胰岛细胞衰老以延缓糖尿病。
Exp Mol Med. 2025 Aug;57(8):1861-1877. doi: 10.1038/s12276-025-01521-1. Epub 2025 Aug 25.
2
Evaluation of Silybin Nanoparticles against Liver Damage in Murine Infection.水飞蓟宾纳米颗粒对小鼠感染性肝损伤的评估
Pharmaceutics. 2024 May 4;16(5):618. doi: 10.3390/pharmaceutics16050618.
3
Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives.

本文引用的文献

1
Effect of ursodeoxycholic acid on glycemic markers: A systematic review and meta-analysis of clinical trials.熊去氧胆酸对血糖标志物的影响:临床试验的系统评价和荟萃分析。
Pharmacol Res. 2018 Sep;135:144-149. doi: 10.1016/j.phrs.2018.08.008. Epub 2018 Aug 9.
2
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.熊去氧胆酸通过苯丙氨酸/酪氨酸途径和肝功能障碍患者的微生物组重塑改善肝功能。
Sci Rep. 2018 Aug 8;8(1):11874. doi: 10.1038/s41598-018-30349-1.
3
Future trends in the treatment of non-alcoholic steatohepatitis.
了解熊去氧胆酸和肠道微生物群在非酒精性脂肪性肝病中的作用:当前证据与展望。
Front Pharmacol. 2024 Mar 21;15:1371574. doi: 10.3389/fphar.2024.1371574. eCollection 2024.
4
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study.法尼酯X受体(FXR)在饮食和年龄影响的代谢变化及肝脏疾病发展中的重要作用:一项多组学研究
Biomark Res. 2023 Feb 18;11(1):20. doi: 10.1186/s40364-023-00458-9.
5
Chardonnay Marc as a New Model for Upcycled Co-products in the Food Industry: Concentration of Diverse Natural Products Chemistry for Consumer Health and Sensory Benefits.霞多丽马克作为食品工业中再利用副产物的新模式:为消费者健康和感官效益集中多样化的天然产物化学。
J Agric Food Chem. 2022 Dec 7;70(48):15007-15027. doi: 10.1021/acs.jafc.2c04519. Epub 2022 Nov 21.
6
Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review.熊去氧胆酸在治疗和预防特异质性药物性肝损伤中的作用。一项系统评价。
Front Pharmacol. 2021 Oct 27;12:744488. doi: 10.3389/fphar.2021.744488. eCollection 2021.
7
Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver.比较姜黄素和熊去氧胆酸对乙醇诱导的大鼠肝损伤的保护作用。
Ethiop J Health Sci. 2021 May;31(3):673-682. doi: 10.4314/ejhs.v31i3.25.
8
Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD.代谢指纹图谱揭示了肺结核相关慢性阻塞性肺疾病与吸烟所致慢性阻塞性肺疾病表型之间的差异。
Front Med (Lausanne). 2021 May 14;8:619077. doi: 10.3389/fmed.2021.619077. eCollection 2021.
9
Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles.利用粪便微生物细胞外囊泡的宏基因组和代谢组学数据的结直肠癌诊断模型。
Sci Rep. 2020 Feb 18;10(1):2860. doi: 10.1038/s41598-020-59529-8.
10
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis.全面代谢组学搜索用于区分早期肝细胞癌与肝硬化的生物标志物
Cancers (Basel). 2019 Oct 6;11(10):1497. doi: 10.3390/cancers11101497.
非酒精性脂肪性肝炎治疗的未来趋势
Pharmacol Res. 2018 Aug;134:289-298. doi: 10.1016/j.phrs.2018.07.014. Epub 2018 Jul 17.
4
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism.微生物组介导的胆汁酸修饰:在肠道药物吸收和代谢中的作用。
Pharmacol Res. 2018 Jul;133:170-186. doi: 10.1016/j.phrs.2018.04.009. Epub 2018 Apr 13.
5
Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach.采用尿和血清代谢组学方法鉴定大鼠肝纤维化进展过程中的关键代谢变化。
Sci Rep. 2017 Sep 12;7(1):11433. doi: 10.1038/s41598-017-11759-z.
6
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease.阿尔茨海默病临床和实验样本中胆汁酸的代谢组学分析
Metabolites. 2017 Jun 17;7(2):28. doi: 10.3390/metabo7020028.
7
Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.法尼醇 X 受体激活促进小鼠肝脏氨基酸分解代谢和铵清除。
Gastroenterology. 2017 May;152(6):1462-1476.e10. doi: 10.1053/j.gastro.2017.01.014. Epub 2017 Jan 25.
8
Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury: Multi-Omics Approaches.阿莫西林/克拉维酸诱导的肝损伤生物标志物探索:多组学方法
Clin Transl Sci. 2017 May;10(3):163-171. doi: 10.1111/cts.12425. Epub 2016 Oct 26.
9
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.奥贝胆酸治疗原发性胆汁性胆管炎的安慰剂对照临床试验。
N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840.
10
Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.经肝活检证实的非酒精性脂肪性肝病患者与健康受试者的血浆磷脂和脂肪酸组成存在差异。
Nutr Diabetes. 2016 Jul 18;6(7):e220. doi: 10.1038/nutd.2016.27.